English version

Ph.D. stipendiat i galenisk farmasi

OsloMet –  storbyuniversitetet er landets tredje største universitet, med over 20 000 studenter og mer enn 2000 ansatte. OsloMet leverer kunnskap og yrkesutøvere samfunnet er avhengig av, og er tett på arbeidslivets behov. OsloMet er et urbant og mangfoldig universitet med internasjonalt preg og et attraktivt studie- og arbeidssted med studiesteder midt i Oslo og på Kjeller ved Lillestrøm. Tilstedeværelsen i hovedstadsregionen gir universitetet gode muligheter til å forstå og høste fordelene av byens varierte befolkningssammensetning.

There is a vacancy as a research fellow in a three-year fixed-term position affiliated to the research group ‘Disease and Environmental Exposures’ at the Department of Life Sciences and Health at the Faculty of Health Sciences. More information about the research group can be found here. The tentative starting date has been set to 1 October 2021, but will be finally agreed upon appointment.

The term of the position can be four years, with 25% of the position dedicated to required duties, depending on the applicant’s academic, linguistic and teaching qualifications. This will be decided upon appointment.

Field of research

One of our research group’s focus areas is the formulation and production of pharmaceuticals by means of nanotechnology, and the research fellow will work on developing a safe and efficient nanoparticle pharmaceutical that contains lacritin to treat dry eyes. Lacritin is a protein that is naturally found in tears, where it helps to prevent dry eyes, among other things. The nanoparticles can help to keep the lacritin in the eye for longer. It is a known problem with pharmaceuticals for the eye that they do not remain on the eye for long enough.

The project concerns the production and characterisation of nanoparticles containing lacritin. It also includes monitoring lacritin’s sensitive three-dimensional structure and studying the biological effect of the system by means of cornea cells. Parts of the research will be carried out in collaboration with Oslo University Hospital.



You need

        - TOEFL: 600 (paper-based test), 92 (internet test)
        - IELTS: 6.5, where no part has a score lower than 5.5
        - CAE/CPE: Grade A or B


It is an advantage if you also have:




Desirable qualities

It is important to OsloMet to reflect the population of our region, and all qualified candidates are welcome to apply. We make active endeavours to further develop OsloMet as an inclusive workplace and to make adaptations to the workplace if required. You are also welcome to apply for a position with us if you have had periods where you have not been in employment, education or training.


We offer

The salary for the position is in accordance with the Basic Collective Agreement for state employees and OsloMet’s pay policy for position code 1017 (research fellow), pay grade 54, i.e. an initial annual salary of NOK 482 200.


Further information

For more information about the position, please contact:

OsloMet uses an electronic recruitment system. If you wish to apply for the position, please register your application and CV by clicking the button.


You must upload the following documents together with your application:

We only consider applications submitted through our electronic recruitment system, and all documents must be uploaded in order for your application to be considered. The documents must be in either English or a Scandinavian language. Translations must be government authorised. Originals must be presented if you are invited for an interview OsloMet checks documents in order to give candidates a proper evaluation and ensure fair competition.


Deadline for applications: 24th of May 2021

Ref:                 21/04315


OsloMet er Charter & Code sertifisert av EU-kommisjonen med rettigheter til å bruke logoen HR Excellence in Research (HRS4R) og medlem i nettverket EURAXESS som bidrar til gode arbeidsforhold for mobile forskere. OsloMet har sluttet seg til prinsippene og forpliktet institusjonen til å følge anbefalingene i DORA-erklæringen (sfdora.org) (The San Francisco Declaration on Research Assessment).